Skip to main content

Global Companion Diagnostics Market Is Projected to Reach $7,536.7 Million by 2030

 

As depicted, the genome sequencing cost is decreasing while the production (TB) is increasing. It is expected that the cost of genome sequencing would ultimately drop to as low as $100 by 2025. As a result, it is highly possible that the use of genome sequencing will become more widely adopted and integrated into regular clinical practice, thereby bolstering the scope of companion diagnostic usage across the healthcare continuum for treatment preferences.

As per BIS Research analysis, the global companion diagnostics market is projected to reach $7,536.7 million by 2030 from $1,764.7 million in 2019, at a CAGR of 12.45% during the forecast period of 2020-2030. This growth has been primarily attributed to the major drivers in this market, which comprise the growing incidence of cancer within the global population that has intensified the demand for better treatment assurance for all cancer types. Additionally, the growing demand for personalized medicine and the regulatory mandate for the co-development of drugs and diagnostics are driving the growth of the global CDx market. The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include the development of multiple-biomarker based CDx, powered by NGS technology, commercialization of CDx for non-oncology disease areas, and exploitation of advance data science technology in the field of companion diagnostics. However, there are significant challenges which are restraining the market growth. These challenges include an uncertain reimbursement scenario, companion diagnostics leakage in oncology and weak synchronization between therapeutics and diagnostics in marketing and distribution channels.

The BIS Research report on the global companion diagnostics market segments the market on the basis of technology (in-situ hybridization, immunohistochemistry, polymerase chain reaction, and next-generation sequencing), application area (lung cancer, breast cancer, colorectal cancer, leukemia, melanoma, stomach cancer, and others), and region (North America, Europe, Asia-Pacific, and Rest-of-the-World).

Labels:

Comments

Post a Comment

Popular posts from this blog

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...
Post a Comment
Read more

Strategies Incorporated to Sustain the Competition

  The strategies followed by various prominent companies to sustain the competition and expand their market share has been varying from mergers and acquisitions (M&A) to collaborations and partnerships. In the past three years (January 2017-September 2020), the market witnessed approximately eight M&A activities, seven partnerships, and alliances (collaborations, joint ventures, and other agreements), one business expansion, and four other developments. Among the different key developments, M&A activities constitute the dominant contributor’s strategies, followed by partnership and alliances. The global bioengineered skin substitutes market is dominated by juggernauts including AbbVie, Inc., Integra LifeSciences Corporation, Smith & Nephew plc, and Stryker Corporation, and other medium and small-medium enterprises that are offering wide ranges of bioengineered skin substitute products in the market. Several companies are attempting to enter the market and sustain...
Post a Comment
Read more

Increasing Adoption of Lidar in Construction Applications

  The construction industry is continuously growing and has been witnessing various technological innovations. The construction industry depicts high complexity, steep costs, and low toleration for error, that facilitate the adoption of laser scanning. Lidars have enabled the construction industry to gain 3D models of existing space and build digital plans on those real spaces. Digital collaboration frameworks such as building information modelling (BIM) deliver the value of the scans to every element of a construction team in formats that are best suited to their needs. BIM schematics also provide continuing value to facility maintenance and operation teams. BIS Research Report on Lidar Market Numerous stages of construction projects are scanned for quality assurance, cross-checking with models, and spotting errors. Lidars can also be deployed for quality evaluation of prefabricated materials, allowing an efficient, and cheap evaluation. Furthermore, lidars find applications i...
Post a Comment
Read more